| Manometrical findings | |||||||
---|---|---|---|---|---|---|---|---|
 | Resting pressure (mmHg) | MSP (mmHg) | RST volume (mL) | MBDV causing RAIR (mL) | ||||
EORTC QLQ-CR38 components | r | p | r | p | r | p | r | p |
Functional scales | ||||||||
 Body image (n = 26) | 0.435 | 0.030 | 0.160 | 0.435 | −0.173 | 0.420 | 0.059 | 0.810 |
 Future perspective (n = 25) | 0.081 | 0.714 | 0.189 | 0.365 | −0.276 | 0.214 | −0.024 | 0.931 |
 Sexual functioning (n = 29) | 0.479 | 0.011 | 0.268 | 0.160 | −0.143 | 0.486 | 0.353 | 0.127 |
 Sexual enjoyment (n = 24) | 0.299 | 0.176 | −0.049 | 0.821 | 0.091 | 0.694 | 0.005 | 0.985 |
Symptom scales | ||||||||
 Radiation-induced micturition (n = 29) | −0.263 | 0.186 | 0.015 | 0.937 | −0.091 | 0.659 | −0.411 | 0.072 |
 Chemotherapy side effects (n = 29) | 0.183 | 0.361 | 0.004 | 0.982 | −0.203 | 0.319 | −0.344 | 0.137 |
 Gastrointestinal symptoms (n = 29) | −0.304 | 0.123 | −0.232 | 0.226 | 0.025 | 0.904 | 0.185 | 0.435 |
 Sexual dysfunction of men (n = 11) | −0.087 | 0.812 | −0.304 | 0.364 | 0.464 | 0.176 | 0.268 | 0.254 |
 Sexual dysfunction of women (n = 4) | 0.775 | 0.225 | −0.258 | 0.752 | −0.577 | 0.423 | 0.232 | 0.325 |
 Defecation problems (n = 29) | −0.159 | 0.429 | −0.163 | 0.398 | 0.424 | 0.031 | 0.242 | 0.304 |
 Weight loss (n = 29) | −0.146 | 0.468 | −0.021 | 0.913 | 0.445 | 0.023 | 0.00 | 1.00 |